Canadian Meds |
Policy | Legal
Terms | Meds Index
Omnicef is an antibacterial medical product of the broad-spectrum therapeutic effect. It was approved by FDA in 1997 and up-to-date it is widely used for the treatment of different infectious affections of the body.
Oftentimes, this antibiotic is prescribed for the treatment of the infectious diseases of the respiratory tracts as it copes with them well. These diseases include: infections of the upper respiratory tracts – otitis, sinusitis, pharyngitis; infections of the lower respiratory tracts – pneumonia, bronchitis, and also infections of the soft tissues and mucous membranes.
Due to the strong pharmacological action the main symptoms of the disease are reduced within several days after the beginning of the treatment and a patient can return to the previous lifestyle.
A mechanism of the action of this drug is characterized by its bactericidal properties. Penetrating into the body the active components of this antibiotic reach the infectious cells through the blood. Omnicef slows down the protein satiation of the infected cells as a result of which bacteria stop growing and reproducing. This causes their regression and gradual destruction. Gram-positive and gram-negative morbific microorganisms are sensitive to the action of this drug.
Omnicef is inefficient in the treatment of viruses, and therefore before the beginning of therapy a patient should have a medical examination and find out an exact diagnosis and type of the infection.
When a patient will be diagnosed, a doctor will be able to identify the most optimal dose and prescribe all recommendations for the use of the antibiotic. The dosage is indicated individually depending on the health condition of the patient.
The initial dose for adults is 300 mg 2 times a day (in the morning and evening).
In case of the severe types of the disease the dose can be increased but only according to the recommendations of the medical specialist.
Children are prescribed the dosage individually based on different characteristics: age, weight, duration of the disease, its severity, and presence of the accompanying diseases.
The length of the treatment is 5-14 days.
Omnicef is contraindicated for the use by patients with individual intolerance of the active components of this drug, or increased sensitivity to any cephalosporin’s.
To take the drug during pregnancy consult your attending doctor.
It is strictly prohibited to take the dose more than it is indicated in your prescription because this may cause the overdose.
© 2003-2017 Rx Meds Canada . All Rights Reserved